Loading...
Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
Metastatic brain tumors are the leading cause of central nervous system malignancies in adults, surpassing primary central nervous system with non-small cell lung cancer, accounting for more than 50% of all cases. The emergence of immunotherapies such as antibodies targeting the immune check points...
Saved in:
| Published in: | Cureus |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Cureus
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559690/ https://ncbi.nlm.nih.gov/pubmed/31245230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|